TY - JOUR
T1 - An update on the pathogenesis of cholesterol gallstone disease
AU - Di Ciaula, Agostino
AU - Wang, David Q.H.
AU - Portincasa, Piero
N1 - Funding Information:
The present chapter is written in the context of the project FOIE GRAS, which has received funding from the European Union’s Horizon 2020 Research and Innovation program under the Marie Sklodowska-Curie Grant Agreement No. 722619.
Publisher Copyright:
© Copyright 2018 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2018/3/1
Y1 - 2018/3/1
N2 - Purpose of review Gallstone disease is a major epidemiologic and economic burden worldwide, and the most frequent form is cholesterol gallstone disease. Recent findings Major pathogenetic factors for cholesterol gallstones include a genetic background, hepatic hypersecretion of cholesterol, and supersaturated bile which give life to precipitating cholesterol crystals that accumulate and grow in a sluggish gallbladder. Additional factors include mucin and inflammatory changes in the gallbladder, slow intestinal motility, increased intestinal absorption of cholesterol, and altered gut microbiota. Mechanisms of disease are linked with insulin resistance, obesity, the metabolic syndrome, and type 2 diabetes. The role of nuclear receptors, signaling pathways, gut microbiota, and epigenome are being actively investigated. Summary Ongoing research on cholesterol gallstone disease is intensively investigating several pathogenic mechanisms, associated metabolic disorders, new therapeutic approaches, and novel strategies for primary prevention, including lifestyles.
AB - Purpose of review Gallstone disease is a major epidemiologic and economic burden worldwide, and the most frequent form is cholesterol gallstone disease. Recent findings Major pathogenetic factors for cholesterol gallstones include a genetic background, hepatic hypersecretion of cholesterol, and supersaturated bile which give life to precipitating cholesterol crystals that accumulate and grow in a sluggish gallbladder. Additional factors include mucin and inflammatory changes in the gallbladder, slow intestinal motility, increased intestinal absorption of cholesterol, and altered gut microbiota. Mechanisms of disease are linked with insulin resistance, obesity, the metabolic syndrome, and type 2 diabetes. The role of nuclear receptors, signaling pathways, gut microbiota, and epigenome are being actively investigated. Summary Ongoing research on cholesterol gallstone disease is intensively investigating several pathogenic mechanisms, associated metabolic disorders, new therapeutic approaches, and novel strategies for primary prevention, including lifestyles.
KW - cholesterol crystallization
KW - gallbladder
KW - mucin gel
KW - supersaturated bile
UR - http://www.scopus.com/inward/record.url?scp=85042424066&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042424066&partnerID=8YFLogxK
U2 - 10.1097/MOG.0000000000000423
DO - 10.1097/MOG.0000000000000423
M3 - Review article
C2 - 29283909
AN - SCOPUS:85042424066
SN - 0267-1379
VL - 34
SP - 71
EP - 80
JO - Current Opinion in Gastroenterology
JF - Current Opinion in Gastroenterology
IS - 2
ER -